Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a chinese population

Molecular Carcinogenesis

Volumn 52, Issue 11, 2013, Pages 916-921

  Ma, Zhicheng ^a   Hu, Qingfeng ^a   Chen, Zhuo ^b   Tao, Sha ^b   Macnamara, Lindsay ^b   Kim, Seong Tae ^b   Tian, Lu ^b   Xu, Ke ^a   Ding, Qiang ^a   Zheng, Siqun L ^b   Sun, Jielin ^b   Xia, Guowei ^a   Xu, Jianfeng ^a,b,c  

^a FUDAN UNIVERSITY   (China)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Association studies; Bladder cancer; Chinese; Confirmation; Genome wide; SNPs

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER STAGING; CHINESE; CONTROLLED STUDY; FEMALE; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; PROGENY; QUESTIONNAIRE; RISK ASSESSMENT; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ASIAN CONTINENTAL ANCESTRY GROUP; BLADDER; CHINA; GENETICS; META ANALYSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; URINARY BLADDER NEOPLASMS;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84886302745     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21932     Document Type: Article

References (23)

1. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212-236.
2. Yang L, Parkin DM, Li LD, et al. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 2004; 90:2157-2166.
3. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: From tumor development to patient's death. World J Urol 2007; 25:285-295.
4. Aben KK, Baglietto L, Baffoe-Bonnie A, et al. Segregation analysis of urothelial cell carcinoma. Eur J Cancer 2006; 42:1428-1433.
5. Murta-Nascimento C, Silverman DT, Kogevinas M, et al. Risk of bladder cancer associated with family history of cancer: Do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev 2007; 16:1595-1600.
6. Kiemeney LA, Thorlacius S, Sulem P, et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008; 40:1307-1312.
7. Wu X, Ye Y, Kiemeney LA, et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 2009; 41:991-995.
8. Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010; 42:978-984.
9. Kiemeney LA, Sulem P, Besenbacher S, et al. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet 2010; 42:415-419.
10. Rafnar T, Vermeulen SH, Sulem P, et al. European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet 2011; 20:4268-4281.
11. Garcia-Closas M, Ye Y, Rothman N, et al. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet 2011; 20:4282-4289.
12. Wang S, Tang J, Wang M, et al. Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population. Carcinogenesis 2010; 31:621-624.
13. Wang M, Zhang W, Yuan L, et al. Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population. Carcinogenesis 2009; 30:991-996.
14. Wang M, Chu H, Yan F, et al. Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population. Carcinogenesis 2011; 32:872-875.
15. Gago-Dominguez M, Jiang X, Conti DV, et al. Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: Findings from the Los Angeles-Shanghai bladder case-control study. Carcinogenesis 2011; 32:197-202.
16. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575.
17. Zuiverloon TC, van der Aa MN, van der Kwast TH, et al. Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer. Clin Cancer Res 2010; 16:3011-3018.
18. Patel JH, Loboda AP, Showe MK, et al. Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 2004; 4:562-568.
19. Sakamoto H, Yoshimura K, Saeki N, et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 2008; 40:730-740.
20. Bahrenberg G, Brauers A, Joost HG, et al. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Commun 2000; 275:783-788.
21. Broberg K, Bjork J, Paulsson K, et al. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005; 26:1263-1271.
22. McGrath M, Wong JY, Michaud D, et al. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007; 16:815-819.
23. Thorleifsson G, Walters GB, Gudbjartsson DF, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009; 41:18-24.